Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic N... ( http://www.exelixis.com . Forward-Lo...)

HOME >> MEDICINE >> TECHNOLOGY

Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy

Date:10/16/2007

">http://www.exelixis.com.

Forward-Looking Statements

This press release contains forward-looking statements, including, without limitation, statements related to the future development and potential efficacy, safety and tolerability of XL784 and the timing of the submission of XL784 data to GSK. Words such as "may," "will," "expects" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Exelixis' current expectations. Forward-looking statements involve risks and uncertainties. Exelixis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the results of any failure of XL784 to demonstrate safety and efficacy in clinical testing, risks related to Exelixis' arrangement with SEI and Exelixis' dependence on and relationship with GSK. These and other risk factors are discussed under "Risk Factors" and elsewhere in Exelixis' Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 and Exelixis' other filings with the Securities and Exchange Commission. Exelixis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Exelixis' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS

Post Your Comments:

(Date:5/21/2013)... TEANECK, N.J. , May 21, 2013 /PRNewswire-iReach/ ... 17-19 in NJ has attracted the greatest number ... reports its President, Mark Alexay ... "But suddenly everyone plans to attend this year. The show,s still ... of different companies. This is a big surprise ...

(Date:5/21/2013)... 2013 IsoRay, Inc. (AMEX: ISR ), ... into an exclusive international distribution agreement with IASIS Medical ... Greece . IsoRay is a medical ... radioisotope applications for brain cancer, lung cancer, head and ... IASIS Medical is ideally suited to support ...

(Date:5/21/2013)... 2013 The North Shore-LIJ Health System is expanding ... compliance at North Shore University Hospital in ... rooms at Forest Hills (NY) ... The new pilot program strengthens patient safety by providing ... the first time in the US that remote video ...

Breaking Medicine Technology:Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2 IsoRay Announces A New International Distributor For Greece 2 IsoRay Announces A New International Distributor For Greece 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4

[0] Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show [0] IsoRay Announces A New International Distributor For Greece [0] North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs

... ... ... ... ...

Cached Medicine Technology:Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility 2 Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility 3 Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility 4 Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility 5 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 6 Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 7

Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility Diabetics Twice as Likely to Have Hearing Loss; California HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March

(Date:5/21/2013)... 2013) Prostaglandin analogues (PGAs), drugs which lower intraocular ... people with glaucoma, but their use is not without ... dryness, changes in eye color and other side effects. ... also cause upper and lower eyelid drooping and other ... described in PLOS ONE . , Researchers from ...

(Date:5/21/2013)... May 21, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices, is addressing ... Joint Surgery on May 15, 2013. The study found ... identify complications that occur in patients with metal-on-metal hip ... ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve known ...

(Date:5/21/2013)... HealthSmart continues to grow through strategic acquisitions ... the hiring of new talent in several areas, including ... that Dawn Powell has joined the organization effective April ... Account Management in the Central Region and is based ... extensive client management, employee benefits, and product development experience, ...

(Date:5/21/2013)... 21 May 2013, Paris, France: One-year results from SOURCE ... valve implantation (TAVI) registries to-date reported today at ... practice, with high rates of device success for all ... SOURCE XT Post-Approval Study followed up 2688 consecutively enrolled ... Sapien XT heart valve at 93 centres in 17 ...

(Date:5/21/2013)... AZ (PRWEB) May 21, 2013 ... and inventors who want to develop their ideas ... summer program. , The university is recruiting ... revolutionary new “formation space” that provides early-stage entrepreneurs ... While AREA48 is open to anyone, ASU is ...

Breaking Medicine News(10 mins):Health News:Glaucoma drug can cause droopy eyelids 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2 Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3 Health News:New Talent Joins the HealthSmart Account Management Team 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3 Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4

[0] Glaucoma drug can cause droopy eyelids [0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants [0] New Talent Joins the HealthSmart Account Management Team [0] Post-approval TAVI registry shows high rates of device success at 1 year [0] ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors

... Long Island Patient Information eXchange (LIPIX) went live with ... accessing LIPIX online systems. LIPIX realizes the value ... through its HIE, but also understands that it is ... that the information will be protected. "As more ...

... But weight training can boost strength in other ways, researchers ... did not build muscle mass in octogenarian women but still ... conducted by Ball State University in Indiana finds. , ... three times a week for three months on a machine ...

... to Self-Report Suspected MeaslesHARRISBURG, Pa., April 3 The Pennsylvania ... Department and UPMC,s Children,s Hospital of Pittsburgh today confirmed they ... Hospital. Exposures to measles may have occurred in the Children,s ... , March 10, at ...

... /PRNewswire-FirstCall/ - The Westaim Corporation today announced that ... to maximize the value of the Company,s strong ... strategy, Westaim has entered into a management services ... an affiliate of Goodwood Inc., to manage the ...

... 3 eDiets.com, Inc. (Nasdaq: DIET ... healthy lifestyle solutions, today announced that it received a notice ... of the Company,s listed securities has fallen below $35 million, ... Market, in compliance with NASDAQ Marketplace Rule 4310(c)(3)(B). The ...

... the toxin in leg bones are tied to poorer scores on ... higher levels of environmental lead earlier in the life span may ... a new study finds. , The Harvard study shows that women ... blood (indicating a recent exposure to the metal) or bones (an ...

Cached Medicine News:Health News:LIPIX Protects Access to Electronic Health Information With the Anakam Identity Suite(R) 2 Health News:LIPIX Protects Access to Electronic Health Information With the Anakam Identity Suite(R) 3 Health News:Muscle Mass Won't Grow in Women Over 80 2 Health News:Pennsylvania State Department of Health and Allegheny County Health Department Confirm Four Cases of Measles in Southwest Region 2 Health News:Pennsylvania State Department of Health and Allegheny County Health Department Confirm Four Cases of Measles in Southwest Region 3 Health News:Westaim enters into Management Services Agreement 2 Health News:eDiets.com(R) Receives NASDAQ Notice Regarding Market Value of Listed Securities 2 Health News:eDiets.com(R) Receives NASDAQ Notice Regarding Market Value of Listed Securities 3 Health News:Accumulated Lead May Affect Older Women's Brains 2

LIPIX Protects Access to Electronic Health Information With the Anakam Identity Suite(R)Muscle Mass Won't Grow in Women Over 80 Pennsylvania State Department of Health and Allegheny County Health Department Confirm Four Cases of Measles in Southwest Region Westaim enters into Management Services Agreement eDiets.com(R) Receives NASDAQ Notice Regarding Market Value of Listed Securities Accumulated Lead May Affect Older Women's Brains

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

Medicine Products:

Epithelial Skin Antibody Epithelial Basement Membrane Zone IgG Antibodies Epinephrine, Plasma Ephedrine, Urine